{"id":"https://openalex.org/W2493372949","doi":"https://doi.org/10.1093/hmg/ddw238","title":"Pridopidine activates neuroprotective pathways impaired in Huntington Disease","display_name":"Pridopidine activates neuroprotective pathways impaired in Huntington Disease","publication_year":2016,"publication_date":"2016-07-27","ids":{"openalex":"https://openalex.org/W2493372949","doi":"https://doi.org/10.1093/hmg/ddw238","mag":"2493372949","pmid":"https://pubmed.ncbi.nlm.nih.gov/27466197","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5291233"},"language":"en","primary_location":{"id":"doi:10.1093/hmg/ddw238","doi":"https://doi.org/10.1093/hmg/ddw238","is_oa":true,"landing_page_url":"https://doi.org/10.1093/hmg/ddw238","pdf_url":"https://academic.oup.com/hmg/article-pdf/25/18/3975/9983419/ddw238.pdf","source":{"id":"https://openalex.org/S166515463","display_name":"Human Molecular Genetics","issn_l":"0964-6906","issn":["0964-6906","1460-2083"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human Molecular Genetics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://academic.oup.com/hmg/article-pdf/25/18/3975/9983419/ddw238.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051218483","display_name":"Michal Geva","orcid":"https://orcid.org/0000-0002-6949-0963","observed_orcids":["https://orcid.org/0000-0002-6949-0963"]},"institutions":[{"id":"https://openalex.org/I4210109720","display_name":"Teva Pharmaceuticals (Israel)","ror":"https://ror.org/01wfv3m53","country_code":"IL","type":"company","lineage":["https://openalex.org/I4210109720"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Michal Geva","raw_affiliation_strings":["Teva Pharmaceutical Industries Ltd, Petach Tikva, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Teva Pharmaceutical Industries Ltd, Petach Tikva, Israel","institution_ids":["https://openalex.org/I4210109720"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000179485","display_name":"Rebecca L. Kusko","orcid":"https://orcid.org/0000-0001-6730-5990","observed_orcids":["https://orcid.org/0000-0001-6730-5990"]},"institutions":[{"id":"https://openalex.org/I4391767868","display_name":"Immuneering (United States)","ror":"https://ror.org/00awq8a10","country_code":"US","type":"company","lineage":["https://openalex.org/I4391767868"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rebecca Kusko","raw_affiliation_strings":["Immuneering Corporation, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immuneering Corporation, Cambridge, MA, USA","institution_ids":["https://openalex.org/I4391767868"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034898819","display_name":"Holly D Soares","orcid":"https://orcid.org/0000-0002-6140-9841","observed_orcids":["https://orcid.org/0000-0002-6140-9841"]},"institutions":[{"id":"https://openalex.org/I4210109720","display_name":"Teva Pharmaceuticals (Israel)","ror":"https://ror.org/01wfv3m53","country_code":"IL","type":"company","lineage":["https://openalex.org/I4210109720"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Holly Soares","raw_affiliation_strings":["Teva Pharmaceutical Industries Ltd, Petach Tikva, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Teva Pharmaceutical Industries Ltd, Petach Tikva, Israel","institution_ids":["https://openalex.org/I4210109720"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Kevin D. Fowler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4391767868","display_name":"Immuneering (United States)","ror":"https://ror.org/00awq8a10","country_code":"US","type":"company","lineage":["https://openalex.org/I4391767868"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kevin D. Fowler","raw_affiliation_strings":["Immuneering Corporation, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immuneering Corporation, Cambridge, MA, USA","institution_ids":["https://openalex.org/I4391767868"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072895924","display_name":"Tal Birnberg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210109720","display_name":"Teva Pharmaceuticals (Israel)","ror":"https://ror.org/01wfv3m53","country_code":"IL","type":"company","lineage":["https://openalex.org/I4210109720"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Tal Birnberg","raw_affiliation_strings":["Teva Pharmaceutical Industries Ltd, Petach Tikva, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Teva Pharmaceutical Industries Ltd, Petach Tikva, Israel","institution_ids":["https://openalex.org/I4210109720"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112747532","display_name":"Steve Barash","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210109720","display_name":"Teva Pharmaceuticals (Israel)","ror":"https://ror.org/01wfv3m53","country_code":"IL","type":"company","lineage":["https://openalex.org/I4210109720"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Steve Barash","raw_affiliation_strings":["Teva Pharmaceutical Industries Ltd, Petach Tikva, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Teva Pharmaceutical Industries Ltd, Petach Tikva, Israel","institution_ids":["https://openalex.org/I4210109720"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042927796","display_name":"A. Merenlender Wagner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210109720","display_name":"Teva Pharmaceuticals (Israel)","ror":"https://ror.org/01wfv3m53","country_code":"IL","type":"company","lineage":["https://openalex.org/I4210109720"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Avia Merenlender -Wagner","raw_affiliation_strings":["Teva Pharmaceutical Industries Ltd, Petach Tikva, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Teva Pharmaceutical Industries Ltd, Petach Tikva, Israel","institution_ids":["https://openalex.org/I4210109720"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009671613","display_name":"Tania Fine","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210109720","display_name":"Teva Pharmaceuticals (Israel)","ror":"https://ror.org/01wfv3m53","country_code":"IL","type":"company","lineage":["https://openalex.org/I4210109720"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Tania Fine","raw_affiliation_strings":["Teva Pharmaceutical Industries Ltd, Petach Tikva, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Teva Pharmaceutical Industries Ltd, Petach Tikva, Israel","institution_ids":["https://openalex.org/I4210109720"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005985307","display_name":"Andrew C. Lysaght","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4391767868","display_name":"Immuneering (United States)","ror":"https://ror.org/00awq8a10","country_code":"US","type":"company","lineage":["https://openalex.org/I4391767868"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew Lysaght","raw_affiliation_strings":["Immuneering Corporation, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immuneering Corporation, Cambridge, MA, USA","institution_ids":["https://openalex.org/I4391767868"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034798965","display_name":"Brian Weiner","orcid":"https://orcid.org/0000-0002-7285-4385","observed_orcids":["https://orcid.org/0000-0002-7285-4385"]},"institutions":[{"id":"https://openalex.org/I4391767868","display_name":"Immuneering (United States)","ror":"https://ror.org/00awq8a10","country_code":"US","type":"company","lineage":["https://openalex.org/I4391767868"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian Weiner","raw_affiliation_strings":["Immuneering Corporation, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immuneering Corporation, Cambridge, MA, USA","institution_ids":["https://openalex.org/I4391767868"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102821450","display_name":"Yoonjeong Cha","orcid":"https://orcid.org/0009-0004-6211-1301","observed_orcids":["https://orcid.org/0009-0004-6211-1301"]},"institutions":[{"id":"https://openalex.org/I4391767868","display_name":"Immuneering (United States)","ror":"https://ror.org/00awq8a10","country_code":"US","type":"company","lineage":["https://openalex.org/I4391767868"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yoonjeong Cha","raw_affiliation_strings":["Immuneering Corporation, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immuneering Corporation, Cambridge, MA, USA","institution_ids":["https://openalex.org/I4391767868"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059021503","display_name":"Sarah E. Kolitz","orcid":"https://orcid.org/0009-0007-7596-6765","observed_orcids":["https://orcid.org/0009-0007-7596-6765"]},"institutions":[{"id":"https://openalex.org/I4391767868","display_name":"Immuneering (United States)","ror":"https://ror.org/00awq8a10","country_code":"US","type":"company","lineage":["https://openalex.org/I4391767868"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sarah Kolitz","raw_affiliation_strings":["Immuneering Corporation, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immuneering Corporation, Cambridge, MA, USA","institution_ids":["https://openalex.org/I4391767868"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023113485","display_name":"Fadi Towfic","orcid":"https://orcid.org/0000-0001-6756-647X","observed_orcids":["https://orcid.org/0000-0001-6756-647X"]},"institutions":[{"id":"https://openalex.org/I4391767868","display_name":"Immuneering (United States)","ror":"https://ror.org/00awq8a10","country_code":"US","type":"company","lineage":["https://openalex.org/I4391767868"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fadi Towfic","raw_affiliation_strings":["Immuneering Corporation, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immuneering Corporation, Cambridge, MA, USA","institution_ids":["https://openalex.org/I4391767868"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014020354","display_name":"Aric Orbach","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210109720","display_name":"Teva Pharmaceuticals (Israel)","ror":"https://ror.org/01wfv3m53","country_code":"IL","type":"company","lineage":["https://openalex.org/I4210109720"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Aric Orbach","raw_affiliation_strings":["Teva Pharmaceutical Industries Ltd, Petach Tikva, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Teva Pharmaceutical Industries Ltd, Petach Tikva, Israel","institution_ids":["https://openalex.org/I4210109720"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111594821","display_name":"Ralph Laufer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210109720","display_name":"Teva Pharmaceuticals (Israel)","ror":"https://ror.org/01wfv3m53","country_code":"IL","type":"company","lineage":["https://openalex.org/I4210109720"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Ralph Laufer","raw_affiliation_strings":["Teva Pharmaceutical Industries Ltd, Petach Tikva, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Teva Pharmaceutical Industries Ltd, Petach Tikva, Israel","institution_ids":["https://openalex.org/I4210109720"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037686701","display_name":"Ben Zeskind","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4391767868","display_name":"Immuneering (United States)","ror":"https://ror.org/00awq8a10","country_code":"US","type":"company","lineage":["https://openalex.org/I4391767868"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ben Zeskind","raw_affiliation_strings":["Immuneering Corporation, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immuneering Corporation, Cambridge, MA, USA","institution_ids":["https://openalex.org/I4391767868"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112194696","display_name":"Iris Grossman","orcid":"https://orcid.org/0000-0003-3912-7458","observed_orcids":["https://orcid.org/0000-0003-3912-7458"]},"institutions":[{"id":"https://openalex.org/I4210109720","display_name":"Teva Pharmaceuticals (Israel)","ror":"https://ror.org/01wfv3m53","country_code":"IL","type":"company","lineage":["https://openalex.org/I4210109720"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Iris Grossman","raw_affiliation_strings":["Teva Pharmaceutical Industries Ltd, Petach Tikva, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Teva Pharmaceutical Industries Ltd, Petach Tikva, Israel","institution_ids":["https://openalex.org/I4210109720"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5047722409","display_name":"Michael R. Hayden","orcid":"https://orcid.org/0000-0001-5159-1419","observed_orcids":["https://orcid.org/0000-0001-5159-1419"]},"institutions":[{"id":"https://openalex.org/I4210109720","display_name":"Teva Pharmaceuticals (Israel)","ror":"https://ror.org/01wfv3m53","country_code":"IL","type":"company","lineage":["https://openalex.org/I4210109720"]}],"countries":["IL"],"is_corresponding":true,"raw_author_name":"Michael R. Hayden","raw_affiliation_strings":["Teva Pharmaceutical Industries Ltd, Petach Tikva, Israel Michael.Hayden@teva.co.il","Teva Pharmaceutical Industries Ltd, Petach Tikva, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Teva Pharmaceutical Industries Ltd, Petach Tikva, Israel Michael.Hayden@teva.co.il","institution_ids":["https://openalex.org/I4210109720"]},{"raw_affiliation_string":"Teva Pharmaceutical Industries Ltd, Petach Tikva, Israel","institution_ids":["https://openalex.org/I4210109720"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5047722409"],"corresponding_institution_ids":["https://openalex.org/I4210109720"],"apc_list":{"value":4390,"currency":"USD","value_usd":4390},"apc_paid":{"value":4390,"currency":"USD","value_usd":4390},"fwci":3.7074,"has_fulltext":true,"cited_by_count":83,"citation_normalized_percentile":{"value":0.94496146,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"25","issue":"18","first_page":"3975","last_page":"3987"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10949","display_name":"Genetic Neurodegenerative Diseases","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10949","display_name":"Genetic Neurodegenerative Diseases","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10919","display_name":"Deep Brain Stimulation and Movement Disorders","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pridopidine","display_name":"pridopidine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/huntington-s-disease","display_name":"Huntington's disease","score":0.9950000047683716},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.8510000109672546},{"id":"https://openalex.org/keywords/sigma-1-receptor","display_name":"sigma-1 receptor","score":0.9319999814033508},{"id":"https://openalex.org/keywords/dopamine-d1-receptor","display_name":"dopamine D1 receptor","score":0.7480000257492065},{"id":"https://openalex.org/keywords/glucocorticoid-receptor","display_name":"glucocorticoid receptor","score":0.996999979019165},{"id":"https://openalex.org/keywords/akt-pi3k-pathway","display_name":"AKT/PI3K pathway","score":0.9610000252723694},{"id":"https://openalex.org/keywords/striatum","display_name":"striatum","score":0.7540000081062317},{"id":"https://openalex.org/keywords/gene-expression-profiling","display_name":"gene expression profiling","score":0.8769999742507935},{"id":"https://openalex.org/keywords/neuroplasticity","display_name":"neuroplasticity","score":0.6970000267028809},{"id":"https://openalex.org/keywords/mechanism-of-action","display_name":"mechanism of action","score":0.621999979019165}],"concepts":[{"id":"https://openalex.org/C103133801","wikidata":"https://www.wikidata.org/wiki/Q408572","display_name":"Sigma-1 receptor","level":4,"score":0.7036212682723999},{"id":"https://openalex.org/C25498285","wikidata":"https://www.wikidata.org/wiki/Q1981368","display_name":"Neuroprotection","level":2,"score":0.681303858757019},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.5568305253982544},{"id":"https://openalex.org/C2780647506","wikidata":"https://www.wikidata.org/wiki/Q190564","display_name":"Huntington's disease","level":3,"score":0.5290780663490295},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.44874992966651917},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.42063841223716736},{"id":"https://openalex.org/C59493245","wikidata":"https://www.wikidata.org/wiki/Q14877410","display_name":"Glucocorticoid receptor","level":3,"score":0.4183777868747711},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.41594868898391724},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.28496426343917847},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2815282642841339},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.2420807182788849},{"id":"https://openalex.org/C2780841215","wikidata":"https://www.wikidata.org/wiki/Q422549","display_name":"Glucocorticoid","level":2,"score":0.22842583060264587},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.22759857773780823},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.21584570407867432},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.20381322503089905},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.10825654864311218},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.0598924458026886}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003342","descriptor_name":"Corpus Striatum","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003342","descriptor_name":"Corpus Striatum","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D003342","descriptor_name":"Corpus Striatum","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005786","descriptor_name":"Gene Expression Regulation","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006816","descriptor_name":"Huntington Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006816","descriptor_name":"Huntington Disease","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D006816","descriptor_name":"Huntington Disease","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011965","descriptor_name":"Receptors, Glucocorticoid","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D011965","descriptor_name":"Receptors, Glucocorticoid","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016678","descriptor_name":"Genome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018696","descriptor_name":"Neuroprotective Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D018696","descriptor_name":"Neuroprotective Agents","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D019208","descriptor_name":"Brain-Derived Neurotrophic Factor","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":true},{"descriptor_ui":"D019208","descriptor_name":"Brain-Derived Neurotrophic Factor","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D050641","descriptor_name":"Receptors, Dopamine D5","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D050641","descriptor_name":"Receptors, Dopamine D5","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1093/hmg/ddw238","doi":"https://doi.org/10.1093/hmg/ddw238","is_oa":true,"landing_page_url":"https://doi.org/10.1093/hmg/ddw238","pdf_url":"https://academic.oup.com/hmg/article-pdf/25/18/3975/9983419/ddw238.pdf","source":{"id":"https://openalex.org/S166515463","display_name":"Human Molecular Genetics","issn_l":"0964-6906","issn":["0964-6906","1460-2083"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human Molecular Genetics","raw_type":"journal-article"},{"id":"pmid:27466197","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27466197","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human molecular genetics","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:5291233","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5291233/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hum Mol Genet","raw_type":"Text"},{"id":"pmh:oai:open-archive.highwire.org:hmg:25/18/3975","doi":null,"is_oa":false,"landing_page_url":"http://hmg.oxfordjournals.org/cgi/content/short/25/18/3975","pdf_url":null,"source":{"id":"https://openalex.org/S4406923041","display_name":"HighWire Press Open Archive","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"TEXT"}],"best_oa_location":{"id":"doi:10.1093/hmg/ddw238","doi":"https://doi.org/10.1093/hmg/ddw238","is_oa":true,"landing_page_url":"https://doi.org/10.1093/hmg/ddw238","pdf_url":"https://academic.oup.com/hmg/article-pdf/25/18/3975/9983419/ddw238.pdf","source":{"id":"https://openalex.org/S166515463","display_name":"Human Molecular Genetics","issn_l":"0964-6906","issn":["0964-6906","1460-2083"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human Molecular Genetics","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320308970","display_name":"Teva Pharmaceutical Industries","ror":"https://ror.org/01wfv3m53"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2493372949.pdf","grobid_xml":"https://content.openalex.org/works/W2493372949.grobid-xml"},"referenced_works_count":58,"referenced_works":["https://openalex.org/W1515218878","https://openalex.org/W1608359448","https://openalex.org/W1722048355","https://openalex.org/W1907647691","https://openalex.org/W1911782737","https://openalex.org/W1967291680","https://openalex.org/W1985560386","https://openalex.org/W1987210736","https://openalex.org/W1987433942","https://openalex.org/W1991543633","https://openalex.org/W1995540460","https://openalex.org/W2003888864","https://openalex.org/W2012423618","https://openalex.org/W2015973598","https://openalex.org/W2019969295","https://openalex.org/W2023545568","https://openalex.org/W2027394430","https://openalex.org/W2029962300","https://openalex.org/W2031211058","https://openalex.org/W2031936045","https://openalex.org/W2035083384","https://openalex.org/W2036602491","https://openalex.org/W2044712342","https://openalex.org/W2047193476","https://openalex.org/W2050801235","https://openalex.org/W2059722505","https://openalex.org/W2060650451","https://openalex.org/W2066028783","https://openalex.org/W2067592930","https://openalex.org/W2068227599","https://openalex.org/W2074000839","https://openalex.org/W2081861269","https://openalex.org/W2094612064","https://openalex.org/W2095949552","https://openalex.org/W2097744565","https://openalex.org/W2106289426","https://openalex.org/W2110054485","https://openalex.org/W2113069845","https://openalex.org/W2119839582","https://openalex.org/W2125527752","https://openalex.org/W2129625926","https://openalex.org/W2130410032","https://openalex.org/W2135306800","https://openalex.org/W2136751299","https://openalex.org/W2138879784","https://openalex.org/W2143935514","https://openalex.org/W2145648240","https://openalex.org/W2149104590","https://openalex.org/W2151310421","https://openalex.org/W2151732475","https://openalex.org/W2155611657","https://openalex.org/W2167353335","https://openalex.org/W2168358500","https://openalex.org/W2168699664","https://openalex.org/W2169735361","https://openalex.org/W2170243036","https://openalex.org/W2740215628","https://openalex.org/W4406061008"],"related_works":["https://openalex.org/W1925196301","https://openalex.org/W3005646971","https://openalex.org/W2335075857","https://openalex.org/W2806871172","https://openalex.org/W2946645772","https://openalex.org/W4390262307","https://openalex.org/W2788319007","https://openalex.org/W4294723716","https://openalex.org/W2547401413","https://openalex.org/W2898283052"],"abstract_inverted_index":{"Pridopidine":[0,95,164],"has":[1],"demonstrated":[2],"improvement":[3],"in":[4,15,57,70,126,189,222,239],"Huntington":[5],"Disease":[6],"(HD)":[7],"motor":[8],"symptoms":[9,242],"as":[10,20,181,183],"measured":[11],"by":[12,88],"secondary":[13],"endpoints":[14],"clinical":[16,31],"trials.":[17],"Originally":[18],"described":[19],"a":[21,205],"dopamine":[22],"stabilizer,":[23],"this":[24],"mechanism":[25],"is":[26],"insufficient":[27],"to":[28,65,123,131,175,185],"explain":[29],"the":[30,58,66,90,97,117,143,151,201,209,216],"and":[32,63,103,150,171,179],"preclinical":[33],"effects":[34,235],"of":[35,44,48,92,116,167,194,208,211,213,243],"pridopidine.":[36,214],"This":[37],"study":[38],"therefore":[39],"explored":[40],"pridopidine's":[41],"potential":[42],"mechanisms":[43],"action.":[45],"The":[46],"effect":[47,105,199],"pridopidine":[49,140,231],"versus":[50],"sham":[51],"treatment":[52,141],"on":[53,106,200],"genome-wide":[54],"expression":[55,68,166],"profiling":[56],"rat":[59],"striatum":[60],"was":[61,85,109],"analysed":[62],"compared":[64,130],"pathological":[67],"profile":[69],"Q175":[71,127],"knock-in":[72],"(Q175":[73],"KI)":[74],"vs":[75],"Q25":[76],"WT":[77,132],"mouse":[78],"models.":[79,192],"A":[80],"broad,":[81],"unbiased":[82],"pathway":[83,99,153],"analysis":[84],"conducted,":[86],"followed":[87],"testing":[89],"enrichment":[91],"relevant":[93],"pathways.":[94],"upregulated":[96,142],"BDNF":[98,107,202],"(P":[100,154],"=":[101,155,158,161],"1.73E-10),":[102],"its":[104,198,237],"secretion":[108],"sigma":[110],"1":[111],"receptor":[112,145],"(S1R)":[113],"dependent.":[114],"Many":[115],"same":[118],"genes":[119,149],"were":[120],"independently":[121],"found":[122],"be":[124],"downregulated":[125,221],"KI":[128],"mice":[129],"(5.2e-7":[133],"<":[134,136],"P":[135,157,160],"0.04).":[137],"In":[138],"addition,":[139],"glucocorticoid":[144],"(GR)":[146],"response,":[147],"D1R-associated":[148],"AKT/PI3K":[152,172],"1E-10,":[156],"0.001,":[159],"0.004,":[162],"respectively).":[163],"upregulates":[165],"BDNF,":[168],"D1R,":[169],"GR":[170],"pathways,":[173],"known":[174],"promote":[176],"neuronal":[177],"plasticity":[178],"survival,":[180],"well":[182],"reported":[184],"demonstrate":[186],"therapeutic":[187],"benefit":[188],"HD":[190],"animal":[191],"Activation":[193],"S1R,":[195],"necessary":[196],"for":[197],"pathway,":[203],"represents":[204],"core":[206],"component":[207],"mode":[210],"action":[212],"Since":[215],"newly":[217],"identified":[218],"pathways":[219],"are":[220],"neurodegenerative":[223],"diseases,":[224],"including":[225],"HD,":[226],"these":[227],"findings":[228],"suggest":[229],"that":[230],"may":[232],"exert":[233],"neuroprotective":[234],"beyond":[236],"role":[238],"alleviating":[240],"some":[241],"HD.":[244]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":13},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":11},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":10},{"year":2018,"cited_by_count":12},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-08-23T00:00:00"}